Navigation Links
Thoratec Presentation at Bear Stearns Conference To Be Webcast
Date:9/10/2007

PLEASANTON, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in products to treat cardiovascular disease, said today that it will be participating in the Bear Stearns 2007 Healthcare Conference on Tuesday, September 11.

Gary Burbach, president and chief executive officer, will provide an update on the company, beginning at 3 p.m., Eastern Daylight Time (12 p.m., Pacific Daylight Time).

The presentation will be available through the conference website http://cc.talkpoint.com/BEAR002/091007a_sc/?entity=thoratec and on the company's website at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's websites at http://www.thoratec.com or http://www.itcmed.com.


'/>"/>
SOURCE Thoratec Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. New Sonic Foundry search engine finds words, phrases in video presentations
2. Sonic Foundry creates search engine for 7,000 expert video presentations
3. InvestMidWest calls for business presentations
4. BxVideo designs Web hosting service for Sonic Foundry media presentations
5. Distance Education Conference Selects Sonic Foundry to Make Keynotes, Panel Presentations Available On-Demand
6. Digital Healthcare Conference 2007: Mounting obstacles for health IT
7. Biomedical engineering conference invites manufacturers
8. Conference to address small town development
9. Wisconsin to host SBIR Conference
10. Gaming conference explores interactive media in learning
11. Digital Healthcare Conference starts on a realistic note
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2008)...HILL, N.C., Oct. 9 /- Pairing traditi...tworking and multi-channel marketing,are helping o...ons and stay,afloat financially in today,s market....s in Recessions, the 10th annual quality excellenc...L BENCHMARKING COUNCIL,executives from leading co...
(Date:10/9/2008)...umber 7 out of top 20 Employers Across Life Scienc...e/ -- EMD Serono, Inc., an affiliate,of Merck KGaA...been named,by Science magazine as a top employer i... ranking number 7 out of the top 20 employers,acro...cientific community has recognized EMD Serono,as a...
(Date:10/9/2008)...PTON, Pa., Oct. 9 /- Enviro...C" or the "Company") BioMedical,Division today ann...) XD,Monoplace Hyperbaric Chambers to Comprehensiv...hcare Solutions, a growing company who focuses,sol...itutes throughout the,United States, has purchased...
(Date:10/9/2008)...s to be used to support the achievement of several...stones of Acasti Pharma, LAVAL, QC, Oct. 9 /PRNew...ne Technologies & Bioressources Inc. ("Neptune") (...Company successfully completed as of,October 8, 20...debentures,for gross proceeds of $2,750,000., The...
Breaking Biology Technology:Six Sigma and Social Media: Tools for Reducing Costs, Improving Processes 2EMD Serono Named as a Top Employer by Science Magazine 2Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions 2Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions 3Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions 4Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 2Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 3Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 4
... , , , , , , For total ..., , , , , , , ... , RNeasy Protect ... , , , ..., , RNeasy Protect...
... , , , , , , Optimized ... 293, and CHO cells , , Features a...cols for COS-7, NIH/3T3, HeLa, 293, and CHO cells ... No removal of transfection complexes requi...rum , High efficiency, Economi...
... , , , , , , For purifi...d or cosmid DNA , , Features and b... plasmid DNA , Yields of up to 10 mg pl...f plasmid DNA , Fast and simple procedu... * Actual yields depend on plasmid copy number, s...
... , , , , , , High-quali...s efficient , gene silencing in eukaryotic ... , mRNA. This effect, termed RNA interferen...g in functional genomics studies. Now, QIAGEN offe...is service that includes a range of modifications ...
Other Biology Technology:RNeasy Mini, Midi, and Maxi Kits 2RNeasy Mini, Midi, and Maxi Kits 3RNeasy Mini, Midi, and Maxi Kits 4PolyFect Transfection Reagent 2PolyFect Transfection Reagent 3PolyFect Transfection Reagent 4EndoFree Plasmid Kits 2EndoFree Plasmid Kits 3EndoFree Plasmid Kits 4Custom and library siRNA for efficient gene silencing 2Custom and library siRNA for efficient gene silencing 3Custom and library siRNA for efficient gene silencing 4
(Date:10/10/2008)...LLAHASSEE, Fla. -- In a groundbreaking study led b...University, researchers have discovered that as em... there are dramatic corresponding changes to the o..., The findings bridge a critical knowledge gap fo...derstand the enormously complex process by which D...
(Date:10/10/2008)...DA, MD October 7, 2008 The world,s top scientist... gather in Philadelphia to present their latest re...,American Society of Human Genetics (ASHG) from Tu..., 2008, at the Pennsylvania Convention Center., F...embership organization for human genetics,special...
(Date:10/10/2008)... Yamanaka MD, PhD, of Kyoto University and the Gla...has taken another step forward in improving the po...ed pluripotent stem (iPS) cell technology. , Pre...an be reprogrammed to become embryonic stem cellli...our genes required to reprogram the cells, and a v...
(Date:10/10/2008)...chers from the Peninsula Medical School in Plymout... one hour of moderate exercise a day recommended t...o tackle the rising problem of childhood obesity. ...recent issue of the journal "Archives of Diseases ...Bird study, which has followed the development of ...
Breaking Biology News(10 mins):Landmark study unlocks stem cell, DNA secrets to speed therapies 2Landmark study unlocks stem cell, DNA secrets to speed therapies 3The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 2The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 3The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 4The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 5Yamanaka eliminates viral vector in stem cell reprogramming 2Recommendations for children's exercise lacking say experts 2Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 1Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 2Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 3Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 4Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 5Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 4592 1Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 4592 2Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 4592 3Kiadis Pharma Receives Orphan Drug Designation for Rhitol 28TM 29 From the FDA 4587 1Kiadis Pharma Receives Orphan Drug Designation for Rhitol 28TM 29 From the FDA 4587 2Clinical guidelines for the manual titration of PAP in OSA patients published in JCSM 16796 1Clinical guidelines for the manual titration of PAP in OSA patients published in JCSM 16796 2
...he fascinating interactions between flowers and th...ersity of plants. In order to entice pollinators s...cessfully pollinate their flowers, plants have evo...ch nectar is best known. , Thirty years ago, rese...ted by butterflies contain substantial amounts of ...
...lephants learn to imitate sounds that are not typi...r humans of vocal learning in a non-primate terres...ature, further supports the idea that vocal learni...relationships among animals that separate and reun...s, and bats. , Researchers from the Amboseli Trust...
...cientists at the University of Cincinnati (UC) Col...adly type of secondary stroke known as cerebral va...the brain, cerebral vasospasm usually occurs three...as hemorrhagic stroke. Sixty percent of patients w...nd 40 percent of them die from it. , Vasospasm, s...
...or all its promise, the prospect of using nanopart...ucts has raised concerns about possible harmful ef...e University of Michigan are addressing those conc...ticles damage cell membranes—enough to cause cell ...ented. , "If you,re inventing these sorts of mater...
Other Biology News:Elephants imitate sounds as a form of social communication 2Researchers discover molecule that causes secondary stroke 2Probing The Promise And Perils Of Nanoparticles 2Probing The Promise And Perils Of Nanoparticles 3
...ostics Cytomegalovirus (CMV) pp65 Antigenemia Immu...litative identification of lower matrix protein pp... Kit Components: Erythrocyte Lysis Buffer - (...buffered ammonium chloride. (NH4CL) Fixation Solu...
The CultureWell cell culture systems provide an integrated set-up for preparing cultured cells for staining and imaging. Each system uses medical-grade silicone gaskets preassembled with standard opt
nuclear cap binding protein subunit 1, 80kDa, mRNA
GOAT ANTI SLI
Biology Products: